The MR analysis by Ruth et al. revealed potential causal effects of sex hormones on hormone-sensitive cancers and indicated that higher bioavailable testosterone levels increased the risk of prostate cancer and estrogen receptor-positive breast cancer50. This evidence concerns the gene ESR1 and prostate cancer.